Labshake search
Citations for R&D Systems :
1851 - 1900 of 3688 citations for En 1948 4 Marker Pcb Extraction Spike 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2023Quote: ... Monocyte-derived-dendritic cells (moDC) were obtained by incubation of monocytes with 1 ng/mL of granulocytes-macrophages colony-stimulating factor (GM-CSF, R&D Systems, France) and Interleukin-4 (R&D Systems ...
-
bioRxiv - Microbiology 2023Quote: ... Harvested cells were cultured in RPIM 1640 medium containing 20% porcine serum and 10 ng/mL recombinant porcine granulocyte-macrophage colony-stimulating factor (GM-CSF, R&D Systems, UK) to differentiate mature bone marrow-derived macrophage (BMDMs ...
-
bioRxiv - Cell Biology 2023Quote: ... 3 independent vials of iCell microglia were seeded at 5 x 104 cells per well across 3 independent 96-well plates and treated the following day with vehicle or 5 ng/mL human IFN-β (R&D Systems). Cells were treated for 6 or 24 h prior to collection and stored at −80°C prior to RNA extraction.
-
bioRxiv - Neuroscience 2023Quote: ... Neurospheres were transferred to Matrigel-coated plates and cultured in Neural Medium (DMEM/F12 medium supplemented with N2, N2, and 20 ng ml-1 of basic FGF (R&D Systems Inc.)) for two weeks to generate a monolayer of hNPCs ...
-
bioRxiv - Immunology 2023Quote: ... in PBS and HUVECs were plated at confluence and were stimulated with 40 ng/ml recombinant human TNF-α (210-TA; R&D Systems) and/or 50 ng/ml IFN-γ (285-IF ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were fed with 10 ng/mL of neurotrophic factors (BDNF, GDNF, IGF-1 from R&D systems, NT3 from Stem Cell Technologies), ascorbic acid (2.27 µM) ...
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells were allowed to recover for 5 min and were treated with 10 ng/ml PDGF-AA (PDGFRα homodimer cells) or PDGF-BB (PDGFRα/β heterodimer and PDGFRβ homodimer cells) ligand (R&D Systems) for the indicated amount of time ...
-
bioRxiv - Cell Biology 2023Quote: ... PDGFRα homodimer cells and PDGFRβ homodimer cells at ∼60–70% confluence or PDGFRα/β heterodimer cells at ∼70-80% confluence were serum starved for 24 h in HITES medium and stimulated with 10 ng/ml PDGF-AA (PDGFRα homodimer cells) or PDGF-BB (PDGFRα/β heterodimer and PDGFRβ homodimer cells) ligand (R&D Systems) for the indicated length of time ...
-
bioRxiv - Cell Biology 2023Quote: ... the cells were cultured in N2B27 with 10 ng/ml mouse basic fibroblast growth factor (bFGF) recombinant proteins (R&D systems #313FB025/CF). On Day 2 ...
-
bioRxiv - Molecular Biology 2023Quote: ... For FGF2 treatment sub-confluent MIO-M1 cell cultures were serum starved overnight prior to treatment with 1 ng/ml FGF2 (R&D Systems, USA) and 10 μg/ml heparin for indicated times ...
-
bioRxiv - Cancer Biology 2024Quote: ... A time course was performed on cells treated with 300 ng/mL of recombinant mouse VEGF-B186 (R&D Systems #767-VE-010) for 0 ...
-
bioRxiv - Genomics 2024Quote: ... 5 mM beta-glycerophosphate and 1% insulin-transferrin-selenous acid (osteogenic media) and stimulated them the next day with recombinant human BMP2 (300 ng/ml) (R&D Systems, MN) in serum-free osteogenic media ...
-
bioRxiv - Systems Biology 2023Quote: Where indicated the cells were stimulated with the final concentration of 10 ng/ml of recombinant human TNF-α protein (R&D Systems) or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human interleukin 4 (IL-4) (R&D Systems), Alpha MEM with nucleosides (StemCell Technologies ...
-
bioRxiv - Developmental Biology 2021Quote: ... FGF2 (250 ng/dose; R&D systems), BMS309403 (Millipore Sigma) ...
-
bioRxiv - Systems Biology 2020Quote: ... NT3 (10 ng/µL, R&D Systems) and the small molecules CHIR99021 (2 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... NT3 (10 ng/μL, R&D Systems), as well as with db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2020Quote: ... FGF2 (200 ng/dose; R&D systems), insulin (1μg/dose ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 ng/μL mCSF1 (R&D Systems). Microglia were counted using a haemocytometer and plated out onto 24 or 96-well plates (Corning ...
-
bioRxiv - Neuroscience 2022Quote: ... FGF2 (250 ng/dose; R&D systems), and DZNexp4 (10 µg/dose in DMSO ...
-
bioRxiv - Immunology 2023Quote: ... TNF (0.1 ng/µl, R&D systems), IL-10 (200 U/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... FGF2 (250 ng/dose; R&D systems), BMS309403 (Millipore Sigma) ...
-
bioRxiv - Neuroscience 2023Quote: ... FGF2 (250 ng/dose; R&D systems). 5-Ethynyl-2-deoxyuridine (EdU ...
-
bioRxiv - Neuroscience 2023Quote: ... FGF2 (250 ng/dose; R&D systems), and insulin (1 µg/dose ...
-
bioRxiv - Cancer Biology 2022Quote: Mouse primary GBM cell lines were treated with 100 pM IL-1β (R&D Systems, 401-ML/CF) for 10 ...
-
bioRxiv - Immunology 2021Quote: ... were seeded on 6 well plate and cultured with recombinant mouse IFNγ (100 units/mL; R&D Systems) and recombinant human IL-1β (5 units/mL ...
-
bioRxiv - Neuroscience 2022Quote: ... 50-100μg of protein lysate was treated for 6-8hrs with chABC (100 μU/mL; R&D systems) before being subjected to traditional western blotting ...
-
bioRxiv - Immunology 2022Quote: ... which were coated with 0.5 µg/mL of rhEphA2 (R&D Systems, Minneapolis, MN, USA: #3035-A2-100) or poly-L-lysine (Sigma ...
-
bioRxiv - Immunology 2022Quote: ... were coated with 100 μl per well of 1.5 μg/ml human recombinant integrin αvβ6 (R&D Systems) diluted in coating buffer from the ELISA Starter Accessory Kit (Bethyl Laboratories ...
-
bioRxiv - Immunology 2023Quote: ... a 50:50 mixture of Matrigel Matrix GF and 4 mg/ml Cultrex Rat Collagen I (R&D Systems). For time-lapse live imaging experiments ...
-
bioRxiv - Pathology 2022Quote: Antibody responses were measured against recombinant beta-SARS-CoV-2 B.1.351 spike protein (S) and its receptor binding domain (RBD) (10777-CV and 10735-CV, R&D Systems) by ELISA as previously described [23] ...
-
bioRxiv - Biophysics 2023Quote: ... 100 μL of isolated EV sample was mixed with 4 μL of Alexa488 anti-human TNFRSF10B antibody (FAB6311G, R&D Systems, Minneapolis, MN) and 2 μL of PE anti-human CD63 antibody (561925 ...
-
bioRxiv - Cell Biology 2022Quote: Cells were characterised using hPSC imaging kit (Human Pluripotent Stem Cell Marker Antibody Panel kit, SC008, R&D system, UK) with analysis performed on a flow cytometer (Beckman Coulter Cytomics FC 500) ...
-
bioRxiv - Developmental Biology 2021Quote: Meiosis was induced after 3 days of mitotic expansion culture as previously reported (Miyauchi et al, 2017, 2018) by a combined treatment of 300 ng/ml BMP2 (R&D Systems, 355-BM) and 100 nM RA ...
-
bioRxiv - Biophysics 2020Quote: ... cells were changed to long term DMEM/F12 media50 in the presence or absence of 3 ng/ml TGF-β1 (R&D Systems, Abingdon, UK). Media was replenished three times per week ...
-
bioRxiv - Cell Biology 2021Quote: ... media was replaced with RPMI supplemented with B27 without insulin and containing 1 µM CHIR99021 and 5 ng/ml BMP4 (R&D systems #314-BP). After an additional 48 hours (Day 3) ...
-
bioRxiv - Molecular Biology 2020Quote: ... cells were washed twice with PBS and stimulated with cytokine cocktail consisting of IL-1β (5 ng/ml, R&D Systems, Minneapolis, MN, USA), and IFN-γ (50 ng/ml ...
-
bioRxiv - Microbiology 2021Quote: ... were cultured for 7 days in RPMI supplemented with 5% decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, #216-MC) to obtain MDMs ...
-
bioRxiv - Pathology 2022Quote: ... BMMs were plated into 96-well or 24-well plates (3 × 104 cells per milliliter) in complete α-MEM culture media supplemented with 50 ng/mL RANKL (R&D Systems, USA) and 25 ng/mL M-CSF (PeproTech ...
-
bioRxiv - Bioengineering 2020Quote: ... Microvascular fragment-containing gels were cultured in serum-free media supplemented with 10 ng/mL recombinant human vascular endothelial growth factor (rhVEGF; R&D Systems, Minneapolis, MN) (55) ...
-
bioRxiv - Systems Biology 2021Quote: ... we added one or combinations of the following recombinant proteins to the medium: 200 ng/mL of recombinant mouse FGF4 (R&D Systems, #7486-F4), 200 ng/mL of recombinant human FGF5 (R&D Systems ...
-
bioRxiv - Molecular Biology 2019Quote: ... cells were serum starved overnight and then incubated with 10 ng/ml recombinant human transforming growth factor-beta 1 (TGF-β1) (R&D Systems, Minneapolis, MN) for indicated times.
-
bioRxiv - Bioengineering 2020Quote: ... medium was removed and the scaffolds designated for study in normal growth media were placed in wells with fresh normal growth medium and the mineralized collagen-AM scaffolds designated for study in inflammatory conditions were placed in wells with inflammatory medium (1 ng/ml of IL-1β recombinant porcine protein (R&D Systems, Minneapolis, MN) added to normal growth media) ...
-
bioRxiv - Genetics 2020Quote: ... culture medium was replaced with KSR medium (Chambers et al., 2009, 2011) supplemented with 200 ng/ml of recombinant human Noggin (R&D Systems, Minneapolis, USA) and 10 μM of SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2021Quote: ... cells were starved for 5 hours in DermaLife Basal Medium followed by stimulation with human recombinant IL-17A (R&D systems, 50 ng/ml) and TNF-α (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... On days 27 to 40 organoids were fed on alternate days with media containing 20 ng/mL NT-3 (R&D Systems, 267-N3) and 10 ng/mL BDNF (R&D Systems 248-BD) ...
-
bioRxiv - Developmental Biology 2022Quote: ... re-plated and incubated in 10-cm non-adherent Petri dishes in cSFDM containing 2 ng/ml rhActivin A (R&D Systems, #338-AC), 3 ng/ml rhBMP4 (R&D Systems ...
-
bioRxiv - Microbiology 2023Quote: ... and 50 mmol/L β-mercaptoethanol] supplemented with recombinant mouse stem cell factor (SCF) (12.5 ng/mL; R&D Systems, Cat. No. 455-MC) and recombinant mouse IL-3 (10 ng/mL ...
-
bioRxiv - Physiology 2023Quote: ... 1nM) in VEH for 60 minutes prior to the addition of recombinant human TGF-β1 (5 ng/ml; R&D Systems, Minneapolis, MN, USA). At 6 ...